NAMWISE project aims to drive the adoption and integration of New Approach Methodologies (NAMs) for the assessment of the safety and efficacy of chemicals and pharmaceuticals. By providing a comprehensive set of recommendations, guidance, and training resources, NAMWISE seeks to validate and implement NAMs effectively. The project adopts a definition of NAMs that excludes vertebrate-based data and models, focusing on in vitro approaches (including organoids and organ-on-chips), in silico methods, Adverse Outcome Pathways (AOP), and Integrated Approaches to Testing and Assessment (IATA).
Company Details
- Employees
- 2
- Address
- Regulatory Challenges
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Namwise Questions
Namwise's LinkedIn profile is https://www.linkedin.com/company/namwise
Namwise has
2 employees.
View email and phone details for 2
employees at Namwise.
Namwise's industry is
Biotechnology Research
Namwise's top competitors are
Vitrocell Systems Gmbh,
Gis Fc3r,
Altertox,
Axelera,
Biohive,
Alvéole,
Cehtra,
Pitech Group,
Netri,
4dcell.
Namwise's categories are Biotechnology Research
